The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1391
May 28, 2012
View Complete Issue         Table of Contents 2019 
Choice of Drugs for Heparin-Induced Thrombocytopenia
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Choice of Drugs for Heparin-Induced Thrombocytopenia
May 28, 2012 (Issue: 1391)
A reader has asked us to review the choice of drugs for heparin-induced thrombocytopenia (HIT), a prothrombotic state with high morbidity and mortality. Three recent publications have made somewhat different recommendations on its treatment.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: Choice of Drugs for Heparin-Induced Thrombocytopenia
Article code: 1391b
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.